Back to Clinical Trials Overview
Back To Cancer Clinical Trials
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
Principal Investigator(s): Linus T. Chuang
A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865, IND #7921) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327)Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus
Principal Investigator(s): Monica Prasad-Hayes
Back To Cancer Clinical Trials
Your search for "Corpus Uteri" returned 2 results:
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
Principal Investigator(s): Linus T. Chuang
A Randomized Phase III Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF With Bevacizumab (NSC #704865, IND #7921) Versus Docetaxel (NSC #628503) and Gemcitabine (NSC #613327)Plus G-CSF With Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus
Principal Investigator(s): Monica Prasad-Hayes
Contact Us
Office of Research Services (ORS)
Tel: 212-824-7294
Send e-mail
Related Resources
For Patients
- Find a Mount Sinai Doctor
- Find a Mount Sinai Department or Institute
- Research Match
- Clinicaltrials.gov
- National Cancer Clinical Trials
- Video - Participating in Research - You Can Be Part of the Answer
- The Center for Information & Study on Clinical Research Participation
- Patients Like Me
For Investigators
- Office of Research Services (ORS)
- How to Post Research Projects on the Website
- Conduits
- Research Information Technology
- Communicating with Research Subjects